Electrocore LLC
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation ("nVNS") technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster … Read more
Electrocore LLC (ECOR) - Net Assets
Latest net assets as of September 2025: $-1.07 Million USD
Based on the latest financial reports, Electrocore LLC (ECOR) has net assets worth $-1.07 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($21.41 Million) and total liabilities ($22.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.07 Million |
| % of Total Assets | -5.01% |
| Annual Growth Rate | N/A |
| 5-Year Change | -68.09% |
| 10-Year Change | N/A |
| Growth Volatility | 41.92 |
Electrocore LLC - Net Assets Trend (2016–2024)
This chart illustrates how Electrocore LLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Electrocore LLC (2016–2024)
The table below shows the annual net assets of Electrocore LLC from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $7.54 Million | +1.37% |
| 2023-12-31 | $7.44 Million | -56.44% |
| 2022-12-31 | $17.09 Million | -53.38% |
| 2021-12-31 | $36.65 Million | +55.00% |
| 2020-12-31 | $23.64 Million | -5.03% |
| 2019-12-31 | $24.90 Million | -62.38% |
| 2018-12-31 | $66.19 Million | +173.98% |
| 2017-12-31 | $-89.47 Million | -46.54% |
| 2016-12-31 | $-61.05 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Electrocore LLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7638358100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.00K | 0.09% |
| Other Comprehensive Income | $114.00K | 1.51% |
| Other Components | $184.51 Million | 2445.82% |
| Total Equity | $7.54 Million | 100.00% |
Electrocore LLC Competitors by Market Cap
The table below lists competitors of Electrocore LLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Inbest Prime IV Inmuebles SOCIMI S.A.
MC:YINB4
|
$34.75 Million |
|
Master Tec Group Berhad
KLSE:0295
|
$34.75 Million |
|
Pitanium Ltd
NASDAQ:PTNM
|
$34.76 Million |
|
Team Inc
NYSE:TISI
|
$34.77 Million |
|
Hong Ho Precision Textile Co Ltd
TW:1446
|
$34.74 Million |
|
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
|
$34.73 Million |
|
GOCL Corporation Limited
NSE:GOCLCORP
|
$34.73 Million |
|
EXACOMPTA CLAIREF. NOM.
F:8KG
|
$34.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Electrocore LLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,442,000 to 7,544,000, a change of 102,000 (1.4%).
- Net loss of 11,886,000 reduced equity.
- New share issuances of 8,300,000 increased equity.
- Other comprehensive income increased equity by 178,000.
- Other factors increased equity by 3,510,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.89 Million | -157.56% |
| Share Issuances | $8.30 Million | +110.02% |
| Other Comprehensive Income | $178.00K | +2.36% |
| Other Changes | $3.51 Million | +46.53% |
| Total Change | $- | 1.37% |
Book Value vs Market Value Analysis
This analysis compares Electrocore LLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.84x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-6.12 | $6.90 | x |
| 2017-12-31 | $-13.90 | $6.90 | x |
| 2018-12-31 | $33.60 | $6.90 | x |
| 2019-12-31 | $12.39 | $6.90 | x |
| 2020-12-31 | $8.85 | $6.90 | x |
| 2021-12-31 | $9.29 | $6.90 | x |
| 2022-12-31 | $3.61 | $6.90 | x |
| 2023-12-31 | $1.35 | $6.90 | x |
| 2024-12-31 | $1.01 | $6.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Electrocore LLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -157.56%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -47.20%
- • Asset Turnover: 1.23x
- • Equity Multiplier: 2.71x
- Recent ROE (-157.56%) is below the historical average (-106.75%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -6192.44% | 0.41x | 0.00x | $-9.59 Million |
| 2017 | 0.00% | -4410.88% | 0.02x | 0.00x | $-26.79 Million |
| 2018 | -85.16% | -5621.66% | 0.01x | 1.12x | $-62.38 Million |
| 2019 | -186.09% | -1888.81% | 0.07x | 1.46x | $-47.57 Million |
| 2020 | -102.18% | -672.55% | 0.11x | 1.37x | $-25.81 Million |
| 2021 | -46.98% | -315.87% | 0.13x | 1.17x | $-20.88 Million |
| 2022 | -129.71% | -257.94% | 0.35x | 1.45x | $-23.87 Million |
| 2023 | -253.08% | -117.49% | 1.00x | 2.16x | $-19.58 Million |
| 2024 | -157.56% | -47.20% | 1.23x | 2.71x | $-12.64 Million |
Industry Comparison
This section compares Electrocore LLC's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $498,972,584
- Average return on equity (ROE) among peers: -54.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Electrocore LLC (ECOR) | $-1.07 Million | 0.00% | N/A | $34.75 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-2.23 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $187.53 Billion |
| Acarix AB (publ) (ACIXF) | $51.88 Million | -150.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $3.82 Million |
| Adm Tronics Unltd (ADMT) | $644.00K | 0.00% | 0.66x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $6.03 Million | -94.15% | 0.22x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $75.02 Million | -52.81% | 0.78x | $732.88K |
| Adapthealth Corp (AHCO) | $24.31K | -2.84% | 11.78x | $916.00 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $8.41 Million |